Job Description
Role & responsibilities
- Lead and manage both the MES team and the Automation team, ensuring efficient project execution and alignment with organizational goals.
- Drive PAS-X MES implementation projects across various phases including design, development, testing, and deployment and Maintenance.
- Oversee integration of PAS-X MES with shop floor equipment & ERP, ensuring seamless data exchange and operational efficiency.
- Manage Level 2 integration efforts with shop floor equipment, focusing on systems like GE iFix SCADA, Kepware OPC, Siemens PLC, and SCADA systems.
- Directly engage in PLC and SCADA programming, troubleshooting, and equipment maintenance activities.
- Maintain PAS-X MES recipes and recipe authoring processes in collaboration with relevant stakeholders.
- Provide technical leadership and guidance to team members, encourage a culture of continuous improvement and technical excellence.
- Collaborate with cross-functional teams including IT, engineering, operations, and quality assurance to ensure successful project outcomes.
Skill & Qualifications:
- Minimum of 6 years of experience in PAS|x MES implementation within the pharmaceutical industry and over all Min 10 years of experience in pharmaceutical Industry.
- Proven experience in integrating MES with shop floor equipment & ERP, particularly with Level 2 systems and SAP.
- Proficiency in GE iFix SCADA, Kepware OPC, Siemens PLC, and other relevant automation/ Historian technologies.
- Hands-on experience in PLC and SCADA programming, configuration, and troubleshooting.
- Strong understanding of equipment maintenance practices and methodologies.
- Experience in MES recipe authoring and managing recipe lifecycles.
- Strong analytical and problem-solving abilities, with a keen attention to detail.
- Bachelors degree in engineering Instrumentation/Computer Science, or related field.
- Familiarity with regulatory requirements and standards in the pharmaceutical industry (e.g., GMP, FDA regulations).
Preferred candidate profile
Candidate should have experience in biotech industry
More Info
Key Skills
About Company
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business.
Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK.
Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests 6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products.
Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.
The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab.
Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.